24th Annual Scientific and Clinical Congress

Register Here

Product Theaters

Product Theaters are located in the Exhibit Hall and are hosted by corporations during coffee breaks and lunch breaks for the duration of the Exhibit Hall. Visit these theaters to see corporations demonstrate their latest products.

THURSDAY, MAY 14, 2015

10:00 am – 10:45 am

PRODUCT THEATER A
Advancing Knowledge of Hypertriglyceridemia
Supported by AstraZeneca

PRODUCT THEATER B
Targeting Weight Regulation Through The GLP-1 Pathway
Supported by Novo Nordisk

PRODUCT THEATER C
A Short History of PCSK9 Discovery and Research
Supported by Sanofi-Regeneron

12:45 pm – 1:30 pm

PRODUCT THEATER A
An Individualized Approach to the Treatment of Adults with Type 2 Diabetes
Supported by Janssen Pharmaceuticals, Inc.

PRODUCT THEATER B
Overcoming Barriers to Managing Obesity as a Chronic Disease
Supported by VIVUS, Inc.

PRODUCT THEATER C
Shifting the Clinical Inertia Paradigm: A Proactive and Individualized Approach
Supported by AstraZeneca

FRIDAY, MAY 15, 2015

10:00 am – 10:45 am

PRODUCT THEATER A
Not-So-Subclinical Cushing’s Syndrome
Supported by Corcept Therapeutics

PRODUCT THEATER B
The Effect of a Once-Weekly Therapy on A1C and Weight Over 3 Years
Supported by AstraZeneca

PRODUCT THEATER C
The Risks and Rewards of Bariatric Surgery for the T2DM, Obese Patient
Supported by Ethicon

12:45 pm – 1:30 pm

PRODUCT THEATER A
New Thyroid Nodule Guidelines and Afirma GEC: Implications for Your Practice
Supported by Veracyte

PRODUCT THEATER B
SGLT2 and DPP‐4 Inhibition: Multiple Options for Improved Glycemic Control in Adults with Type 2 Diabetes
Supported by Boehringer Ingelheim Pharmaceuticals, Inc. / Lilly USA, LLC

PRODUCT THEATER C
LDL Cholesterol in Diabetes and the Role of PCSK9 in Cholesterol Homeostasis
Supported by Amgen

5:15 pm – 6:00 pm

PRODUCT THEATER A
Examining the Data Radioactive Iodine (RAI) Ablation & Diagnostic Follow-up in Well-Differentiated Thyroid Cancer
Supported by Genzyme, a Sanofi Company

PRODUCT THEATER B
Introducing Toujeo® (insulin glargine injection) U-300
Supported by Sanofi

PRODUCT THEATER C
A Case Study in Treating Adult Patients with Type 2 Diabetes
Supported by Lilly USA, LLC

SATURDAY, MAY 16, 2015

10:00 am – 10:45 am

PRODUCT THEATER A
Lenvima™ Product Theater
Supported by Eisai, Inc.

PRODUCT THEATER B
Supported by NPS Pharma